Radiolabelling rituximab with (99m)Tc in three steps procedure

Lymphomas are the most frequent haematological malignancy. In non-Hodgkin's lymphomas (NHL), more than 90% of tumor cells express the cluster of differentiation (CD) 20 antigen. At the end of frontline therapy, the evaluation of remission is based on computed tomography (CT) and positron emissi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of labelled compounds & radiopharmaceuticals 2015-06, Vol.58 (7), p.274-280
Hauptverfasser:	Fontan, Charlotte, Bezombes, Christine, Salabert, Anne Sophie, Costes, Julien, Lopez, Raphael, Fournie, Jean-Jacques, Avet-Loiseau, Hervé, Coulais, Yvon, Payoux, Pierre, Tafani, Mathieu
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Cell Line, Tumor Humans Mice Radiopharmaceuticals - chemical synthesis Radiopharmaceuticals - pharmacokinetics Rituximab - chemistry Technetium - chemistry Tissue Distribution Tomography, Emission-Computed, Single-Photon
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!